Must admit I did not look at the short levels, when I did I was surprised to see how high they were. Perhaps indicates that the shorters know something I don't....
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025